THE NEW PROSPECT FOR WEIGHT MANAGEMENT ?

Researchers are increasingly examining retatrutide, a novel medication developed by Eli Lilly, as a potential breakthrough in weight management. Different than many earlier approaches, retatrutide is a twin-action agonist targeting both GLP-1 and GIP, chemicals that impact appetite and blood gluc